PBM Transparency Act Advances In Senate And It’s A Far Cry From The Rebate Rule
Executive Summary
Bill aims to lower patient costs in part by engaging the US Federal Trade Commission to shed light on pharmacy benefit manager transactions with health plans, manufacturers and pharmacies.
You may also be interested in...
PBM Vertical Integration Impact Under The Microscope At Senate Hearing
A US Senate Finance Committee has heard divided opinions on the impact of vertical integration among pharmacy benefit managers, with one witness maintaining it may have positive competitive consequences while another condemned the practice outright.
Senate HELP Panel PBM Bill Requires Rebate Pass-Through, But Not To Plan Members
Bipartisan legislation announced by Sens. Sanders and Cassidy also emphasizes pharmacy benefit manager transparency and bans spread pricing.
Bipartisan Senate Finance Framework Takes ‘Measured’ Aim At PBMs
Framework from Sens. Wyden and Crapo, looks like it would change, but not eliminate, the rebate system and gets an initial thumbs up from both the brand and generic drug lobbies.